MOU vs. Treaty: How Geneva's Form Shapes What It Can Do
Why labeling the Geneva framework a memorandum of understanding rather than a treaty changes ratification, enforcement, and the next administration's options on Iran.
The bilateral document moving toward signature in Geneva is described in reporting as a memorandum of understanding, not a treaty. That distinction is not cosmetic. In United States practice, the form an international agreement takes determines who has to approve it, how courts treat it at home, and how much insulation it carries against being unwound by the next administration.
Under Article II of the Constitution, a treaty requires a two-thirds vote of the Senate to take effect. Memoranda of understanding and other executive agreements do not. Both can bind the executive branch as a matter of policy and international good faith, but only a ratified treaty becomes “the supreme Law of the Land” under the Supremacy Clause. That difference echoes through every part of the Geneva framework.
Why a Treaty Was Never on the Table
For a framework built at the speed Geneva has moved on — drafted, vetted, and signed inside a compressed window with regional guarantors in the room — the MOU form is the only realistic vehicle. A treaty would have to clear the Senate Foreign Relations Committee, survive markup, and reach a two-thirds floor vote. Recent treaty practice suggests that path can take years on a contested foreign-policy file, and there is no plausible two-thirds Iran coalition in the current Senate.
That structural reality, more than any policy preference, is what pushed the negotiating team toward a memorandum. It also explains why the document, as reported by Reuters, reads as a bilateral set of commitments anchored to a 60-day follow-on calendar rather than a comprehensive nuclear treaty in the JCPOA mold.
What the MOU Form Buys
The MOU form gives the administration three things it could not get from a treaty in any reasonable time frame.
First, speed. The document can be signed by the vice president on behalf of the executive, as the Wall Street Journal reported is the plan for Geneva, and take effect on signature for the U.S. side. There is no waiting period for Senate action.
Second, flexibility. An MOU is easier to amend, extend, or supplement through side letters and follow-on understandings. The 60-day window built into the Geneva framework is itself a sign that the parties expect to add substance after signing, not before.
Third, deliberate ambiguity. Because the document does not invoke the JCPOA frame or claim the status of a binding international treaty, it can avoid the politically charged language that doomed earlier nuclear understandings in U.S. domestic debate.
What It Costs
Every advantage of the MOU form has a corresponding cost.
An MOU does not carry the legal weight of a treaty in U.S. courts. It does not preempt state law, it does not create private rights of action, and it generally cannot override existing statutes. That matters for sanctions relief in particular: many of the sanctions the Geneva framework would need to soften are statutory, not executive. Easing them durably would require either congressional action or repeated use of waivers — and waivers are by definition reversible.
It also does not bind a future president. The MOU form is the same legal vehicle that made the original JCPOA so vulnerable to reversal. A future administration that wanted to walk away from Geneva could do so by executive action, with the same speed used to sign it.
Finally, MOUs are not always made fully public. While the Geneva text is expected to be published, side letters and annexes built during the 60-day window may not be. That creates congressional oversight risk, particularly if implementing measures touch on classified verification arrangements.
How Congress Still Gets a Vote
The MOU form keeps the Senate out of the up-or-down ratification fight, but it does not remove Congress from the picture. Several levers remain.
The Iran Nuclear Agreement Review Act of 2015 (INARA) requires the administration to submit nuclear agreements with Iran for congressional review and provides a window for a joint resolution of disapproval. Whether the Geneva framework meets the INARA trigger depends on its final text. If it does, Congress gets a structured chance to weigh in even without a ratification vote.
Appropriations gives Congress another lever. Funding for any U.S. obligations under the framework — verification participation, escrow mechanics, or related programs — has to clear the annual cycle. So does any rollback of sanctions that requires statutory change rather than executive waiver.
And the War Powers Resolution and existing AUMFs frame any military dimension of the agreement, including the Gulf posture signals that have accompanied the negotiating window.
What to Watch After Signing
Three signals will tell readers whether the MOU form is holding up in practice.
The first is the text of the document itself, and whether it includes a clear dispute-resolution clause that names a venue and a process. MOUs without dispute mechanisms tend to fray on first disagreement.
The second is the cadence of follow-on side letters during the 60-day window. A steady stream suggests the framework is being built out as designed. Silence suggests the parties are stuck on substance.
The third is congressional posture. An INARA submission, a hearing schedule, and the early statements from Senate Foreign Relations leadership will indicate whether Geneva faces a structured oversight fight or a procedural one.
The MOU form is a constraint on what Geneva can do, but it is also a permission slip for what it is doing now: moving at the speed the moment requires, with the legal durability that question deferred to a later phase.
Found this useful? Share it.
The Daily Strike
One email. Geopolitics, defense, and the news that moves markets — distilled at 7am ET.
No spam. Unsubscribe in one click.


